Metacognitive and Defusion Training for Schizophrenia; Schizotypal Disorder; Delusional Disorder; Brief Psychotic Disorder; Shared Psychotic Disorder; Schizoaffective Disorder; Other Psychotic Disorder Not Due to A Substance or Known Physiological Condition; Unspecified Psychosis Not Due to a Substance or Known Physiological Condition; Manic Episode, Severe With Psychotic Symptoms; Bipolarity, Current Episode Manic Severe With Psychotic Features; Bipolarity, Current Episode Depressed, Severe, With Psychotic Features; depression, Single Episode, Severe With Psychotic Features; depression, Recurrent, Severe With Psychotic Symptoms

This study is exploring psychotherapy or therapy for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

This appears to be a behavioral / psychological / psychosocial study involving Metacognitive and Defusion Training. Phase is mainly useful to check for medication studies and some device studies.

This study may concern people with schizophrenia; age range: From 18 Years to 70 Years. The criteria appear strict, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

This study is sponsored by Max-Planck-Institute of Psychiatry, which appears to be a research institute. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.